Life2, Inc. Completes $1.5M Series A Funding

Healthcare analytics firm investing funds in sales growth & product development

St. Simons Island, GA: June 7, 2017 – Life2, Inc., an innovator in healthcare
analytics & clinical data services announced today the closing of its $1.5M Series A
funding. Morley Device Innovations (MDI) is the sole new investor and Managing
Director Donald A. Johnson will join the Board of Directors. The additional funds will
be used for sales growth and product development of the company’s Length of Stay
Optimization Suite. This platform focuses on the myriad financial and operational risks
facing all acute care hospitals.

“MDI is experienced in quickly analyzing and validating which medical devices will
work and which ones will not work in today’s healthcare market. We have applied this
same acumen to the Life2 technology base and quickly concluded we wanted to be early
investors”, said Donny Johnson.

Mr. Johnson continued:
“Life2 has developed and deployed innovative and
transformative technology that is needed in the healthcare sector today more than ever.
The technology calculates on a daily basis which caregiver actions work and which ones
do not during a patient’s hospital stay. The initial deployment helped reduce avoidable
inpatient days at a 376-bed hospital by over 5,000 days in a single year. This was a
27% reduction resulting in a $10M economic impact for the hospital. These are proven,
impressive and repeatable results that impressed the MDI team. Hospitals must find
ways to improve their financial results while also improving outcomes. The Life2
technology helps on both fronts.”

Sam Wilkes, Founder and Chairman of Life2 stated:
“We wanted a true partner – not
just a venture investor – for our Series A funding. Donny and his team bring a wealth of
healthcare experience and industry contacts that will certainly help accelerate our sales
growth. We look forward to capitalizing on this opportunity.”

Life2’s Length of Stay Optimization Suite delivers new information hospitals do not
have. It provides a prospective look into the future, a Daily Cycle of new insights:
patient based risk stratification, causality determination for selecting actionable
interventions and an automated feedback loop for knowing which actions work and
which ones do not. The platform provides these insights, enhancing existing
management systems via normal hospital workflow. These valuable insights
unquestionably impact results.

About Morley Device Innovations: Morley Device Innovations (MDI) is a team of
seasoned investors, clinical and regulatory affairs specialists, scientists, researchers
and industry veterans. MDI is an affiliate of Morley Research Consortium, an Atlanta,
GA-based Contract Research Organization, with offices in Atlanta, Georgia and
Redwood City, California (Silicon Valley). MDI invests in early to mid-stage
healthcare companies globally to leverage its vast experience of getting products
through worldwide regulatory entities. MDI uses the skill sets, experience, and health
care industry connectivity of a team uniquely capable of acquiring, refining, and
validating medical devices, thereby significantly enhancing the commercial value of its
assets. MDI’s business model mitigates the variables and risk of traditional venture
investing. MDI’s global ecosystem of contacts and affiliates allows us to source,
analyze, invest and exit in shorter time frames with our own internal team from
beginning to end of a product life cycle.

About Life2: Life2 is an innovator in healthcare analytics and clinical data services that
has developed a proprietary risk mitigation platform for the Healthcare Industry. The
platform focuses on the financial and operational risks facing acute care hospitals and
their care continuum partners. By proactively addressing avoidable Lengths of Stay on
a daily patient-by-patient basis, the hospital’s care teams can positively impact revenue,
reimbursements and clinical outcomes. Our platform “sits under” all existing
management systems – feeding valuable new information & insights via normal hospital
workflow.

Contact: Rick Egan, Partner
Life2, Inc.
(404) 805-1812
rick.egan@life2inc.com



Press Releases

Artificial Intelligence Redefines the Paradigm for Sepsis Care – Posted 11/27/2018 VIEW POST

Device Innovations & Life2 Partner On New Software Medical Devices – Posted 01/30/2018 VIEW POST


  • Get In Touch

  •    
  • Life2 in the News